Causes of Prolonged aPTT with Normal PT
A prolonged aPTT with normal PT indicates a defect in the intrinsic coagulation pathway and is most commonly caused by lupus anticoagulant, heparin therapy, or deficiencies of factors VIII, IX, XI, or XII. 1, 2
Primary Diagnostic Categories
The causes can be systematically organized into three main groups:
1. Inhibitors/Anticoagulants (Most Common)
Lupus anticoagulant - The most frequent cause in clinical practice, particularly in asymptomatic patients with accidentally discovered prolonged aPTT 1, 3
- Does NOT cause bleeding despite the name
- Actually associated with thrombotic risk
- Not time-dependent on mixing studies 2
Heparin therapy - Including unfractionated heparin contamination 2, 3
- Check anti-factor Xa assay to confirm
Direct oral anticoagulants - Rivaroxaban can prolong aPTT 4
2. Factor Deficiencies (Less Common)
Intrinsic pathway factors:
Factor VIII deficiency (Hemophilia A or acquired hemophilia A)
Factor IX deficiency (Hemophilia B)
Factor XI deficiency
Factor XII deficiency - Does NOT cause bleeding 2
Contact pathway factors (clinically benign):
Prekallikrein deficiency - Markedly prolonged aPTT but NO bleeding tendency 5, 6
- Corrects with prolonged incubation of mixing study
- Normal viscoelastic testing (TEG) despite prolonged aPTT 5
High molecular weight kininogen deficiency
3. von Willebrand Disease (Type 2N or Type 3)
- Can present with isolated aPTT prolongation due to low Factor VIII
Diagnostic Algorithm
Step 1: Exclude preanalytical errors 7, 8
- Underfilled tube, clotted sample, delayed processing
- Repeat testing if suspected
Step 2: Perform mixing study 2, 8
- Mix patient plasma 1:1 with normal pooled plasma
- Test immediately and after 1-2 hour incubation at 37°C
Immediate correction:
- Suggests factor deficiency
- Proceed to measure Factors VIII, IX, XI, XII 2
No correction (immediate or delayed):
- Suggests inhibitor present
- If time-dependent (worsens after incubation): Factor VIII inhibitor 2
- If NOT time-dependent: Lupus anticoagulant 2
Step 3: Specific testing based on mixing study
If corrects:
- Measure Factor VIII, IX, XI, XII levels 2
- If all normal, consider prekallikrein deficiency (test with prolonged incubation mixing study) 6
If doesn't correct:
- Perform lupus anticoagulant testing (dRVVT, sensitive aPTT) 1
- Check anti-factor Xa assay to exclude heparin
- If lupus anticoagulant negative and bleeding present, measure Factor VIII inhibitor (Bethesda assay) 2
Critical Clinical Distinctions
Bleeding phenotype present:
- Acquired hemophilia A (Factor VIII inhibitor) - requires urgent evaluation 2
- Hemophilia A or B
- Factor XI deficiency (variable bleeding)
- von Willebrand disease
NO bleeding phenotype:
- Lupus anticoagulant (thrombotic risk instead) 1
- Factor XII deficiency 2
- Prekallikrein deficiency 5, 6
- High molecular weight kininogen deficiency
Common Pitfalls
Immediate correction on mixing study does NOT exclude acquired hemophilia A - Factor VIII inhibitors may not be apparent immediately and specific factor assays must still be performed if clinical presentation suggests bleeding disorder 2
Lupus anticoagulant can cause artifactually low factor levels - Repeat factor assays at higher serial dilutions to attenuate this effect 2
Both lupus anticoagulant and Factor VIII inhibitor can coexist - In complex cases, Factor VIII antibody ELISA may be needed to distinguish 2
Testing should ideally be performed before anticoagulation - Heparin and warfarin interfere with interpretation 1
Patient Selection for Testing
High priority for lupus anticoagulant testing: 1
- Unprovoked VTE in patients <50 years
- Arterial thrombosis in young patients
- Thrombosis at unusual sites
- Late pregnancy loss
- Any thrombosis in patients with autoimmune diseases
Moderate priority:
- Accidentally found prolonged aPTT in asymptomatic subjects
- Recurrent early pregnancy loss